Inhaled isoniazid for tuberculosis treatment
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests inhaled isoniazid (medicine) given through a nebulizer to see how well it works and how safe it is. It's for people being treated for tuberculosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with tuberculosis that can be treated with standard drugs.
- You have been on effective TB treatment for at least 2 weeks and your condition is stable or improving.
- You are not pregnant or breastfeeding.
- You have not had a bad reaction to isoniazid before.
- You do not take certain medicines like corticosteroids (unless on a stable low dose), antacids with aluminum, carbamazepine, phenytoin, or theophylline.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests personalized TB treatment schedules based on your individual risk factors. Researchers want to see if matching treatment intensity to your specific situation helps cure TB while minimizing side effects.
This trial tests two drugs, metformin and N-acetylcysteine, to see if they can help your lungs work better after you finish tuberculosis treatment. You may join if you have active TB with lung damage and are starting standard TB therapy.
This study looks at how often the TB drug isoniazid causes liver problems and what factors might predict them. It could help doctors monitor your liver health more safely if you are being treated with isoniazid.
This trial tests a combination of drugs for people with active tuberculosis who have not been treated before. It aims to find a better way to treat TB, even if the bacteria are resistant to some drugs.
This Phase 2 study tests treatment for people with newly diagnosed, drug-susceptible pulmonary (lung) tuberculosis (TB). It aims to see whether the study treatment works well and is safe for curing TB.
This trial tests new combinations of TB medicines for people with active lung TB that is sensitive to standard drugs. It aims to find safer, shorter treatments that work just as well or better than current options.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.